{
    "data": [
        {
            "id": "69a1f19cf2604c0001f49907",
            "title": "Trump Says &#39;There May Or May Not Be Regime Change In Iran,&#39; But What Do Prediction Markets Say?",
            "description": "<div><div class=\"sc-gfrmXj kPLDLR\"><!--$--><p class=\"block core-block\">President <strong>Donald Trump</strong> addressed questions about potential military action against Iran on Friday, stating you “don’t want to, but sometimes you have to.”</p><!--/$--><!--$--><p class=\"block core-block\">The President stated he hadn’t made a decision on using military force and that there “may or may not be regime change in Iran.”</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">Trump made the remarks to reporters before leaving the White House for a trip to Texas.</p><!--/$--><!--$--><p class=\"block core-block\">Traders on <a href=\"https://polymarket.com/event/us-strikes-iran-by/us-strikes-iran-by-march-7-2026-691\" target=\"_blank\">Polymarket</a> are pricing in a 78% chance of a U.S. strike by the end of year, up about eight percentage points from yesterday. The odds of a strike by the end of March are at 65%, up four percentage points. The market has crossed $470 million in volume.</p><!--/$--><!--$--><p class=\"block core-block\">Secretary of State <strong>Marco Rubio</strong> recently <a href=\"https://www.benzinga.com/markets/prediction-markets/26/02/50889083/marco-rubio-says-iran-has-weapons-solely-designed-to-attack-america-but-what-do-prediction-markets-say\" target=\"_blank\">said</a> that Iran possesses conventional weapons \"solely designed to attack America.”</p><!--/$--><!--$--><div class=\"sc-jHrKIi gTZsSs\"></div><!--/$--><!--$--><p class=\"block core-block\">Defense contractors are positioned for a windfall as new <a href=\"https://www.ft.com/content/c2cfb9e5-9ef7-4448-a5a1-414c996d7093\" target=\"_blank\">reporting</a> reveals the U.S. burned through defensive munitions at an alarming rate during the previous Iran flare-up, and faces critical stockpile shortages.</p><!--/$--><!--$--><p class=\"block core-block\">The U.S. fired as many as 150 THAAD missiles defending Israel during last year’s 12-day conflict, according to a regional military official. The U.S. has ordered fewer than 650 THAAD interceptors total since the system went operational around 2010.</p><!--/$--><!--$--><p class=\"block core-block\">The Navy burned through roughly 200 SM-2 and SM-6 missiles by January 2025 during operations against Houthi militants in the Red Sea. Admiral <strong>James Kilby</strong> told Congress in June 2025 that defensive munitions were being expended at an “alarming rate.”</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">Washington could “easily” expend a “whole year’s worth” of critical defensive munitions in just one or two days if Iran launches multiple large salvos, according to <strong>Stacie Pettyjohn</strong>, director of the defense program at the Center for a New American Security.</p><!--/$--><!--$--><p class=\"block core-block\">The Pentagon plans to spend $840 million on 37 THAAD interceptors in fiscal year 2026. For SM-3 missiles, which saw combat for the first time in April 2024, the U.S. will procure only 12 this fiscal year for $445 million.</p><!--/$--><!--$--><h2 class=\"wp-block-heading\">Defense Stocks Could Benefit</h2><!--/$--><!--$--><p class=\"block core-block\">The U.S. is seeking to “turbocharge” production of key munitions by striking multi-year agreements with major manufacturers.</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\"><strong>Lockheed Martin Corporation</strong> <a class=\"ticker-link\" data-exchange=\"NYSE\" data-ticker=\"LMT\" href=\"https://www.benzinga.com/quote/LMT\" rel=\"noopener\" target=\"_blank\">(NYSE:</a><a class=\"ticker\" href=\"https://www.benzinga.com/quote/LMT\" target=\"_blank\">LMT</a>)<!-- --> manufactures THAAD missiles and recently announced plans to quadruple production capacity from 96 to 400 interceptors annually. </p><!--/$--><!--$--><p class=\"block core-block\">CEO <strong>Jim Taiclet</strong> said the company plans to raise capital spending to $5 billion in 2026. The stock is up 1.5% today, and 10% from the start of the year. </p><!--/$--><!--$--><p class=\"block core-block\"><strong>RTX Corporation</strong> <a class=\"ticker-link\" data-exchange=\"NYSE\" data-ticker=\"RTX\" href=\"https://www.benzinga.com/quote/RTX\" rel=\"noopener\" target=\"_blank\">(NYSE:</a><a class=\"ticker\" href=\"https://www.benzinga.com/quote/RTX\" target=\"_blank\">RTX</a>)<!-- -->, through its Raytheon business, produces SM-3, SM-6, and Patriot missile systems. </p><!--/$--><!--$--><div class=\"nativo-placement-in-content-ap\"></div><!--/$--><!--$--><p class=\"block core-block\">The company recently secured a $1 billion contract for SM-3 Block missiles and a $333 million Navy contract for SM-6 production. The stock is up over 1% today, and 2.5% year to date. </p><!--/$--><!--$--><p class=\"block core-block\"><em>Image: Shutterstock</em></p><!--/$--><!--$--><!--/$--><!--$--><div class=\"bz-optimizely-campaign bz-optimizely-campaign-bottom-50942377\" data-nosnippet=\"true\"></div><!--/$--></div></div>",
            "image": "https://www.benzinga.com/files/images/story/2026/02/27/James-Urges-Leaders-Defend-Constituents.jpeg",
            "link": "https://www.benzinga.com/markets/prediction-markets/26/02/50942377/trump-says-there-may-or-may-not-be-regime-change-in-iran-but-what-do-prediction-markets-say",
            "pub_date": "2026-02-28 03:33:51",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "69a1ede2f2604c0001f4965b",
            "title": "What&#39;s Going On BlackSky Shares On Friday?",
            "description": "<div><div class=\"sc-gfrmXj kPLDLR\"><!--$--><p class=\"block core-block\"><strong>BlackSky Technology Inc.</strong> <a class=\"ticker-link\" data-exchange=\"NYSE\" data-ticker=\"BKSY\" href=\"https://www.benzinga.com/quote/BKSY\" rel=\"noopener\" target=\"_blank\">(NYSE:</a><a class=\"ticker\" href=\"https://www.benzinga.com/quote/BKSY\" target=\"_blank\">BKSY</a>)<!-- --> shares are declining on Friday, caught in a broader market downturn. The Nasdaq is down 55 cents while the S&amp;P 500 has shed 79 cents.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>       • BlackSky Technology stock is feeling bearish pressure. <a href=\"https://www.benzinga.com/quote/BKSY\" rel=\"noreferrer noopener\" target=\"_blank\">What’s behind BKSY decline?</a></strong></p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><h2 class=\"wp-block-heading\"><strong>Deal With Rocket Lab</strong></h2><!--/$--><!--$?--><template id=\"B:2\"></template><div></div><!--/$--><!--$--><h2 class=\"wp-block-heading\"><strong>Recent Earnings Release</strong></h2><!--/$--><!--$--><p class=\"block core-block\">BlackSky reported on Thursday quarterly losses of two cents per share, which beat the analyst consensus estimate loss of 21 cents, while sales of $35.214 million missed the analyst <a href=\"https://www.benzinga.com/pressreleases/26/02/b50881761/blacksky-reports-fourth-quarter-and-full-year-2025-results\" target=\"_blank\">consensus estimate of $37.056 million</a>.</p><!--/$--><!--$--><p class=\"block core-block\">The company sees FY26 sales of $120 million-$145 million versus <a href=\"https://www.benzinga.com/calendars/guidance\" target=\"_blank\">$141.759 million analyst estimate</a>.</p><!--/$--><!--$--><div class=\"sc-jHrKIi gTZsSs\"></div><!--/$--><!--$--><h2 class=\"wp-block-heading\"><strong>BKSY Falls Below Key Moving Averages</strong></h2><!--/$--><!--$--><p class=\"block core-block\">BlackSky is currently trading at $17.79, significantly below its key moving averages, which signals bearish momentum. The stock is 17.8% below its 20-day SMA of $21.57 and 21.2% below its 50-day SMA of $22.51. </p><!--/$--><!--$--><p class=\"block core-block\">Over the past 12 months, the stock has gained 22.56%, but it remains near the lower end of its 52-week range, which saw a high of $33.20 and a low of $6.15.</p><!--/$--><!--$?--><template id=\"B:3\"></template><div></div><!--/$--><!--$--><p class=\"block core-block\">The technical indicators reflect the stock’s struggles. The RSI is at 43.02, indicating a lack of strong momentum either way, while the MACD stands at -0.9485, below its signal line at -0.6852, suggesting bearish pressure. These indicators, combined with the stock’s performance relative to its moving averages, paint a picture of current bearish trends.</p><!--/$--><!--$--><h2 class=\"wp-block-heading\"><strong>Communication Services Sector Outperforms BKSY</strong></h2><!--/$--><!--$--><p class=\"block core-block\">BlackSky is notably underperforming in its sector today, with the Communication Services sector itself seeing a modest gain of 46 cents. </p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">Historically, over the past 30 and 90 days, the sector has shown slight increases of 44 cents and $2.10, respectively, indicating a generally stable environment. However, BlackSky’s significant drop today, in contrast to the sector’s gain, could point to investor concerns specific to the company or its immediate business environment.</p><!--/$--><!--$--><h2 class=\"wp-block-heading\"><strong>Analysts Maintain Buy Rating on BKSY</strong></h2><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li><strong>EPS Estimate: </strong>31 cents (Up from 42 cents)</li>\n<li><strong>Revenue Estimate:</strong> $31.59 Million (Up from $29.54 Million)</li>\n</ul><!--/$--><!--$?--><template id=\"B:4\"></template><div></div><!--/$--><!--$--><h2 class=\"wp-block-heading\"><strong>Analyst Consensus &amp; Recent Actions</strong></h2><!--/$--><!--$--><p class=\"block core-block\">The stock carries a Buy Rating with an <a href=\"https://www.benzinga.com/quote/BKSY/analyst-ratings\" target=\"_blank\">average price target</a> of $24.80. Recent analyst moves include:</p><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li><strong>HC Wainwright &amp; Co.</strong>: Buy (Maintains target to $42 on Feb. 27)</li>\n<li><strong>Jefferies</strong>: Initiated with Buy (Target $23 on Dec. 22, 2025)</li>\n<li><strong>HC Wainwright &amp; Co.</strong>: Buy (Raises target to $42 on Oct. 10, 2025)</li>\n</ul><!--/$--><!--$--><h2 class=\"wp-block-heading\"><strong>BKSY Lags Behind Sector Peers</strong></h2><!--/$--><!--$--><p class=\"block core-block\">BlackSky has seen a significant uptick in its performance over the past year, registering a +22.80% increase. Despite this growth, it lags behind the average performance of its peers in the Communications sector.</p><!--/$--><!--$?--><template id=\"B:5\"></template><div></div><!--/$--><!--$--><p class=\"block core-block\"><strong>Performance vs Peer Group:</strong> BlackSky’s year-over-year growth stands at +22.80%, which is below the peer group average of +32.46%. This underperformance by 9.66 percentage points highlights the challenges BlackSky faces in keeping pace with its sector peers. The company’s growth trajectory, while positive, indicates a need for strategic adjustments to close the gap with the broader industry performance.</p><!--/$--><!--$--><h2 class=\"wp-block-heading\"><strong>BKSY Scores High on Benzinga Edge Momentum</strong></h2><!--/$--><!--$--><p class=\"block core-block\">The <a href=\"https://www.benzinga.com/screener\" target=\"_blank\">Benzinga Edge scorecard</a> for BlackSky highlights its strengths and weaknesses compared to the broader market:</p><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li><strong>Momentum</strong>: Bullish (Score: 74.66) — The company shows strong performance momentum relative to the market.</li>\n</ul><!--/$--><!--$--><p class=\"block core-block\"><strong>BKSY Price Action:</strong> BlackSky is currently trading at $17.79, down 11.01% at publication on Friday.</p><!--/$--><!--$--><p class=\"block core-block\"><em>Photo: Canities via Shutterstock</em></p><!--/$--><!--$--><!--/$--><!--$--><div class=\"bz-optimizely-campaign bz-optimizely-campaign-bottom-50941814\" data-nosnippet=\"true\"></div><!--/$--></div></div>",
            "image": "https://www.benzinga.com/files/images/story/2026/02/27/Sunrise-View-Of-Earth-From-Space.jpeg",
            "link": "https://www.benzinga.com/trading-ideas/movers/26/02/50941814/whats-going-on-blacksky-shares-on-friday",
            "pub_date": "2026-02-28 03:17:58",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "69a1ee80f2604c0001f496db",
            "title": "What&#39;s Going On With Novavax Stock On Friday?",
            "description": "<div><div class=\"sc-gfrmXj kPLDLR\"><!--$--><p class=\"block core-block\"><strong>Novavax Inc.</strong> <a href=\"https://www.benzinga.com/quote/NVAX\" rel=\"noreferrer noopener\" target=\"_blank\">(NASDAQ:</a><a class=\"ticker\" href=\"https://www.benzinga.com/quote/NVAX\" target=\"_blank\">NVAX</a>) shares are down on Friday, possibly on profit-taking after the stock rallied on Thursday following the company's <a href=\"https://www.benzinga.com/markets/earnings/26/02/50904546/covid-19-vaccine-maker-novavax-swings-to-profit-as-sales-climb\" rel=\"noreferrer noopener\" target=\"_blank\">announcement of its fourth-quarter</a> and full-year 2025 financial results. </p><!--/$--><!--$--><p class=\"block core-block\">It is worth noting that Novavax has a short interest of <strong>31.41% of its float</strong>.</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><h2 class=\"wp-block-heading\">Novavax Q4 Profit Shift</h2><!--/$--><!--$--><p class=\"block core-block\">Novavax reported a fourth-quarter earnings shift to a profit of 11 cents, <a href=\"https://www.benzinga.com/calendars/earnings\" rel=\"noreferrer noopener\" target=\"_blank\">compared to a loss of 51</a> cents a year ago, with revenue hitting $147 million, a 67% increase year-over-year.</p><!--/$--><!--$--><p class=\"block core-block\">However, the company also projected adjusted total revenue for 2026 between $230 million and $270 million, falling short of the consensus <a href=\"https://www.benzinga.com/calendars/guidance\" rel=\"noreferrer noopener\" target=\"_blank\">estimate of $381.22 million</a>.</p><!--/$--><!--$--><div class=\"sc-jHrKIi gTZsSs\"></div><!--/$--><!--$--><p class=\"block core-block\">In addition, the company announced it expects Non-GAAP R&amp;D and SG&amp;A expenses of $325 million in 2026, $225 million in 2027, and $200 million or less in 2028.</p><!--/$--><!--$--><p class=\"block core-block\">This news follows Novavax’s achievement of key milestones under its <strong>Sanofi SA</strong> <a class=\"ticker-link\" data-exchange=\"NASDAQ\" data-ticker=\"SNY\" href=\"https://www.benzinga.com/quote/SNY\" rel=\"noopener\" target=\"_blank\">(NASDAQ:</a><a class=\"ticker\" href=\"https://www.benzinga.com/quote/SNY\" target=\"_blank\">SNY</a>)<!-- --> agreement and progress towards new partnerships, but the revenue forecast has overshadowed these developments.</p><!--/$--><!--$--><h2 class=\"wp-block-heading\">Novavax Shows Short-Term Strength Amid Downturn</h2><!--/$--><!--$--><p class=\"block core-block\">Currently, Novavax is trading 8.4% above its 20-day simple moving average (SMA) and 9.2% above its 100-day SMA, indicating some short-term strength despite the recent downturn. </p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">Over the past 12 months, shares have shown significant growth and are currently positioned closer to their 52-week highs than lows.</p><!--/$--><!--$--><p class=\"block core-block\">The RSI is at 44.45, which is considered neutral territory, suggesting that the stock is neither overbought nor oversold. Meanwhile, MACD data is not available, but the absence of significant crossovers indicates a stable trend without immediate bullish or bearish pressure.</p><!--/$--><!--$--><p class=\"block core-block\">The combination of neutral RSI and the lack of a MACD signal suggests mixed momentum, indicating that traders should watch for potential breakout or reversal signals in the near term.</p><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li><strong>Key Resistance</strong>: $11.50</li>\n<li><strong>Key Support</strong>: $9.00</li>\n</ul><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\"><strong>Analyst Consensus &amp; Recent Actions:</strong> The stock carries a Hold Rating with an <a href=\"https://www.benzinga.com/quote/NASDAQ:NVAX/analyst-ratings\" rel=\"noreferrer noopener\" target=\"_blank\">average price target</a> of $32.62. Recent analyst moves include:</p><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li><strong>HC Wainwright &amp; Co.</strong>: Buy (Raises Target to $16.00) (Feb. 27)</li>\n</ul><!--/$--><!--$--><p class=\"block core-block\"><strong>NVAX Price Action:</strong> Novavax shares were down 11.30% at $9.93 at the time of publication on Friday, according to <a href=\"https://pro.benzinga.com/dashboard\" rel=\"noreferrer noopener\" target=\"_blank\">Benzinga Pro data</a>.</p><!--/$--><!--$--><p class=\"block core-block\"><em>Photo via Shutterstock</em></p><!--/$--><!--$--><div class=\"bz-optimizely-campaign bz-optimizely-campaign-bottom-50941936\" data-nosnippet=\"true\"></div><!--/$--></div></div>",
            "image": "https://www.benzinga.com/files/images/story/2026/02/27/Novavax-Vaccine.jpeg",
            "link": "https://www.benzinga.com/markets/earnings/26/02/50941936/whats-going-on-with-novavax-stock-on-friday",
            "pub_date": "2026-02-28 03:20:35",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "69a1ecfcf2604c0001f495b2",
            "title": "What&#39;s Behind The Drop In Microsoft Stock?",
            "description": "<div><div class=\"sc-gfrmXj kPLDLR\"><!--$--><p class=\"block core-block\">Shares of <strong>Microsoft Corporation</strong> <a class=\"ticker-link\" data-exchange=\"NASDAQ\" data-ticker=\"MSFT\" href=\"https://www.benzinga.com/quote/MSFT\" rel=\"noopener\" target=\"_blank\">(NASDAQ:</a><a class=\"ticker\" href=\"https://www.benzinga.com/quote/MSFT\" target=\"_blank\">MSFT</a>)<!-- --> are falling Friday as the company tries to reaffirm a strong partnership with OpenAI despite not being included in the AI company’s latest <a href=\"https://www.benzinga.com/markets/prediction-markets/26/02/50938457/inside-sam-altmans-plan-to-benefit-from-the-hegseth-anthropic-feud\" target=\"_blank\">funding and partnerships announcement</a>.</p><!--/$--><!--$--><ul class=\"wp-block-list\">\n<li>Microsoft stock is under selling pressure. <a href=\"https://www.benzinga.com/quote/MSFT\" rel=\"noreferrer noopener\" target=\"_blank\">Why is MSFT stock trading lower?</a></li>\n</ul><!--/$--><!--$--><h2 class=\"wp-block-heading\">OpenAI Announces New Funding Round Sans Microsoft</h2><!--/$--><!--$--><p class=\"block core-block\">OpenAI announced $110B in new investment at a $730B pre-money valuation. This includes $30B from SoftBank, $30B from NVIDIA, and $50B from Amazon. The company also signed a strategic partnership with Amazon and secured next generation inference compute with NVIDIA.</p><!--/$--><!--$--><p class=\"block core-block\">Microsoft, who was not mentioned in the press release, has a mutually beneficial arrangement with OpenAI that started in 2019. Microsoft released a statement Friday saying that its relationship with OpenAI, including revenue shares, IP agreements and Azure as the stateless cloud provider remains unchanged. </p><!--/$--><!--$--><p class=\"block core-block\">Even though Microsoft reaffirmed the relationship, shares still slid. </p><!--/$--><!--$--><h2 class=\"wp-block-heading\">Shares Down Slightly In Regular Trading</h2><!--/$--><!--$--><p class=\"block core-block\"><strong>MSFT Price Action:</strong> Microsoft shares were down 2.17% at $393.01 at the time of publication on Friday, according to <a href=\"https://pro.benzinga.com/dashboard\" target=\"_blank\">Benzinga Pro data</a>.<br/></p><!--/$--><!--$--><p class=\"block core-block\"><em>Image: Shutterstock</em></p><!--/$--><!--$--><div class=\"bz-optimizely-campaign bz-optimizely-campaign-middle-50941689\" data-nosnippet=\"true\"></div><!--/$--></div></div>",
            "image": "https://www.benzinga.com/files/images/story/2026/02/27/Washington--United-States---April-04-202.jpeg",
            "link": "https://www.benzinga.com/trading-ideas/movers/26/02/50941689/whats-behind-the-drop-in-microsoft-stock",
            "pub_date": "2026-02-28 03:14:07",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        },
        {
            "id": "69a1ea2df2604c0001f49329",
            "title": "Examining the Future: CPS Technologies&#39;s Earnings Outlook",
            "description": "<div><div class=\"sc-gfrmXj kPLDLR\"><!--$--><p class=\"block core-block\">CPS Technologies (NASDAQ:<a class=\"ticker\" href=\"https://www.benzinga.com/quote/CPSH\" target=\"_blank\">CPSH</a>) is preparing to release its quarterly earnings on Monday, 2026-03-02. Here's a brief overview of what investors should keep in mind before the announcement.</p><!--/$--><!--$--><p class=\"block core-block\">Analysts expect CPS Technologies to report an <strong>earnings per share</strong> (EPS) of $0.01.</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\">The announcement from CPS Technologies is eagerly anticipated, with investors seeking news of surpassing estimates and favorable guidance for the next quarter.</p><!--/$--><!--$--><p class=\"block core-block\">It's worth noting for new investors that guidance can be a key determinant of stock price movements.</p><!--/$--><!--$--><p class=\"block core-block\">Here's a look at CPS Technologies's past performance and the resulting price change:</p><!--/$--><!--$--><div class=\"sc-jHrKIi gTZsSs\"></div><!--/$--><!--$--><!--/$--><!--$--><h3 class=\"block core-block\">Market Performance of CPS Technologies's Stock</h3><!--/$--><!--$--><p class=\"block core-block\">Shares of CPS Technologies were trading at $4.47 as of February 26. Over the last 52-week period, shares are up 181.71%. Given that these returns are generally positive, long-term shareholders are likely bullish going into this earnings release. </p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><h3 class=\"block core-block\">All You Need to Know About CPS Technologies</h3><!--/$--><!--$?--><template id=\"B:2\"></template><div></div><!--/$--><!--$--><h3 class=\"block core-block\">Financial Insights: CPS Technologies</h3><!--/$--><!--$--><p class=\"block core-block\"><strong>Market Capitalization:</strong> Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.</p><!--/$--><!--$--><div class=\"min-w-[300px] w-[300px] min-h-[250px] raptive-ad-placement mx-auto overflow-hidden min-w-[300px]\"></div><!--/$--><!--$--><p class=\"block core-block\"><strong>Revenue Growth:</strong> CPS Technologies displayed positive results in 3 months. As of 30 September, 2025, the company achieved a solid revenue growth rate of approximately <strong>107.29%</strong>. This indicates a notable increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Information Technology sector.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>Net Margin:</strong> CPS Technologies's financial strength is reflected in its exceptional net margin, which exceeds industry averages. With a remarkable net margin of <strong>2.36%,</strong> the company showcases strong profitability and effective cost management.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>Return on Equity (ROE):</strong> The company's ROE is a standout performer, exceeding industry averages. With an impressive ROE of <strong>1.39%,</strong> the company showcases effective utilization of equity capital.</p><!--/$--><!--$--><div class=\"nativo-placement-in-content-ap\"></div><!--/$--><!--$--><p class=\"block core-block\"><strong>Return on Assets (ROA):</strong> CPS Technologies's ROA stands out, surpassing industry averages. With an impressive ROA of <strong>1.04%</strong>, the company demonstrates effective utilization of assets and strong financial performance.</p><!--/$--><!--$--><p class=\"block core-block\"><strong>Debt Management:</strong> CPS Technologies's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of <strong>0.02</strong>.</p><!--/$--><!--$--><p class=\"block core-block\"><a href=\"https://www.benzinga.com/quote/CPSH/earnings\" target=\"_blank\"><strong>To track all earnings releases for CPS Technologies visit their earnings calendar on our site.</strong></a></p><!--/$--><!--$--><p class=\"block core-block\"><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p><!--/$--></div></div>",
            "image": "https://www.benzinga.com/files/images/story/2025/11/06/earnings_preview_5.jpg",
            "link": "https://www.benzinga.com/insights/earnings/26/02/50941091/examining-the-future-cps-technologiess-earnings-outlook",
            "pub_date": "2026-02-28 03:02:09",
            "source": "benzinga",
            "kind": 1,
            "language": "en"
        }
    ]
}